Esperion Therapeutics Inc... (ESPR)
1.50
-0.11 (-6.83%)
At close: Mar 28, 2025, 3:58 PM
1.50
-0.29%
After-hours: Mar 28, 2025, 07:59 PM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $116.33M, reflecting a 54.14% growth. For the quarter ending September 30, 2024, Esperion Therapeutics generated $51.63M in revenue.
Revenue (ttm)
$116.33M
Revenue Growth
54.14%
Price / Sales Ratio
2.65
Revenue / Employee
$484.73K
Employees
240
Market Cap
297.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 116.33M | +54.14% |
| Dec 31, 2022 | 75.47M | -3.79% |
| Dec 31, 2021 | 78.45M | -65.52% |
| Dec 31, 2020 | 227.55M | n/a |